Douglas Jermasek insider trades

Open-market stock purchases and sales by Douglas Jermasek, EVP, Corporate Strategy at Unicycive Therapeutics, Inc, from SEC Form 4 filings since Nov 21, 2022.

Recent trades

DateStockTradeValue
May 14, 2026UNCY Unicycive Therapeutics, IncBought (not open market)—
May 14, 2026UNCY Unicycive Therapeutics, IncBought (not open market)—

Companies traded

  • UNCY Unicycive Therapeutics, Inc: other filings, last May 14, 2026

Get free alerts when Douglas Jermasek files a new trade →